Greetings from Golden Seeds

Happy New Year! This year, Golden Seeds will be celebrating its 20th anniversary. Golden Seeds was founded with the goal of changing the landscape of angel investing and directing more funding to high-potential women-led companies. And we have achieved this goal and more. As of the end of 2023, Golden Seeds had funded nearly 250 companies and invested almost $180 million. Over 1,000 women and men have been part of this journey and we celebrate our members, entrepreneurs and partners. Look out for more information on activities and events we will be hosting this year in recognition of our 20th anniversary.

News from Our Companies

Oculogica's OcuPro Chosen for Roadside Cannabis Testing Pilot

Oculogica, creator of the EyeBOX concussion diagnostic, has expanded its product line-up and developed a roadside test to detect acute cannabis use. OcuPro aims to provide a reliable and efficient tool for law enforcement to detect recent use and impairment.

OtoNexus Selected for Elite FDA STeP Program

OtoNexus Medical Technologies awarded with the U.S. Food and Drug Administration's Safer Technologies Program (STeP) for ultrasound platform technology that evaluates middle ear infections.

Annual Fund 2024

We are pleased to announce the launch of Golden Seeds Annual Fund 2024, an exclusive benefit for Golden Seeds members. Our third Annual Fund allows fast-track investment diversification in promising women-led companies. This investment option is available to current members and new members that join Golden Seeds by mid-January. The Annual Fund 2024 is expected to close in late January. If interested, please contact membership@goldenseeds.com.

Golden Seeds Thought Leadership

Golden Seeds Co-CEO Jo Ann Corkran appears on Nasdaq TradeTalks Panel

Our Co-CEO Jo Ann Corkran, along with Jeff Saviano and Asher Kraut, joined Jill Malandrino on Nasdaq TradeTalks to discuss emerging themes in venture capital investments for 2024.

Why millennial women are embracing angel investing

Golden Seeds Co-CEO Loretta McCarthy provides input on the empowerment of women angels and the importance of a good network. Learn how industry and cultural changes are reducing long-standing barriers in the world of angel investing.

At over 300 members, Golden Seeds’ angel investors, along with its funds, have invested over $175 million in early-stage women-led companies. On January 5th and February 2nd you’ll have the chance to learn how you can do the same. Join us for our Open House and learn how you can become part of our growing community of like-minded investors who are changing the landscape of angel investing.

Golden Seeds believes that knowledge is the cornerstone of successful investing. That’s why we want to share what we know about angel investing with you. Join us for an upcoming course on the basics of angel investing, how to conduct due diligence, or an industry sector deep dive. Four of our upcoming courses are listed below. See all of our upcoming courses.

Due Diligence Process Training

January 22nd, 2024 at 1:00 PM - 4:00 PM ET

Intro to Angel Investing

January 23rd, 2024 at 12:00 PM - 2:00 PM ET

Cap Tables and Term Sheets Training

January 25th, 2024 at 2:00 PM - 5:00 PM ET

Healthcare Sector Training: Digital & Consumer Health

January 29th, 2024 at 1:30 PM - 3:00 PM ET

First get an understanding of our investment criteria

Join an Information Session - learn more about the basics of angel funding

Attend an Office Hours - an unstructured conversation with Golden Seeds investors about your business

About Golden Seeds

For nearly 20 years, Golden Seeds has been a leader in funding promising women-led companies. Headquartered in New York City, with active chapters in Arizona, Atlanta, Boston, Dallas, Houston, New Jersey, New York, and Silicon Valley, Golden Seeds is one of the largest angel networks in the United States with over 300 members. In total, Golden Seeds’ members and funds have invested over $175 million in over 240 companies.

If you found this newsletter helpful, share it